Inhaled Antibiotic and Biologic Formulations Targeting <i>Pseudomonas aeruginosa</i>

Lower respiratory tract infections caused by <i>Pseudomonas aeruginosa</i> are a global concern. Patients with chronic lung diseases such as cystic fibrosis and non-cystic fibrosis bronchiectasis often do not receive adequate antibiotic delivery through conventional routes. <i>P. aeruginosa</i> empl...

Description complète

Détails bibliographiques

Auteurs principaux:	Prodip Kumar Baral, Jack Dummer, Daniel Pletzer, Shyamal C. Das
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2026-01-01
Collection:	Pharmaceutics
Sujets:	pulmonary delivery nanoparticles microparticles nano-in-micro particles dry powder inhaler antimicrobial peptides
Accès en ligne:	https://www.mdpi.com/1999-4923/18/2/162
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!